¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"subacute myopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±Ù(À°)º´(Áõ)
  • mitochondrial myopathy
    »ç¸³Ã¼±Ù(À°)º´(Áõ)
  • myopathy
    ±Ù(À°)º´(Áõ)
  • subacute
    ¾Æ±Þ¼º-
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º¼¼±Õ½É³»¸·¿°
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • subacute cutaneous lupus erythematosus
    ¾Æ±Þ¼ºÇǺÎÈ«¹Ý·çǪ½º
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myopathy
    ±ÙÀ°º´Áõ
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subacute
    ¾Æ±Þ¼º-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±ÙÀ°º´Áõ
  • myopathy
    ±ÙÀ°º´Áõ
  • mitochondrial myopathy
    »ç¸³Ã¼±ÙÀ°º´Áõ
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • subacute cutaneous l. erythematosus lupus
    ¾Æ±Þ¼ºÇǺÎÈ«¹Ý·çǪ½º
  • subacute sclerotic leukoencephalitis
    (¢¡subacute sclerosing panencephalitis) ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
  • subacute necrotizing myelitis
    ¾Æ±Þ¼º±«»çô¼ö¿°
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
  • subacute
    ¾Æ±Þ¼º-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SBE= subacute bacterial endocarditis
    ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°.
  • granulomatous thyroiditis,subacute
    À°¾ÆÁ¾¼º °©»ó¼±¿°, ¾Æ±Þ¼º
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subacute myopathy
    ¾Æ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • alcoholic myopathy
    ¾ËÄڿüº ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • alcoholic myopathy
    ¾ËÄڿüº ±Ùº´Áõ(¡­àõ ÐÉÜ»ñø)
  • cardiac myopathy
    ½É(Àå)±ÙÁõ(ãýÐÉñø)
  • cardioskeletal myopathy
  • centronuclear myopathy
    Áß½ÉÇÙ¼º±Ùº´Áõ(¡­ú·àõÐÉÜ»ñø)
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ(¡­ÐÉÜ»ñø)
  • congental myopathy
  • cortisone myopathy
    ÄÚ¸£Æ¼¼Õ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • distal myopathy
    ¿øÀ§¼º ±Ùº´Áõ.
  • lipid myopathy
    Áö¹æ±Ùº´Áõ(¡­ÐÉÜ»ñø)
  • myopathy
    ±Ùº´Áõ(ÐÉÜ»ñø).
  • myopathy
    ±Ùº´Áõ
  • myopathy distal
    ¿øÀ§ºÎ±Ùº´Áõ.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subacute
    ¾Æ±Þ¼º(ÀÇ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
HCM Hypertrophic Cardio-Myopathy
  = HCMP
LIMM lethal infantile mitochondrial myopathy
MTM Thayer-Martin, modified [agar]; myotubular myopathy
MTMX myotubular myopathy, X-linked
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CNM Centronuclear myopathy
MM Miyoshi myopathy
MTM1 Myotubular myopathy
PROMM Proximal myotonic myopathy
IIM idiopathic inflammatory myopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subacute asymmetric idiopathic polyneuritis
    ¾Æ±Þ¼º ºñ´ëμº Ư¹ß¼º ´Ù¹ß ½Å°æ¿°
  • subacute bronchopneumonia
    ¾Æ±Þ¼º ±â°üÁö Æó·Å
  • subacute disease
    ¾Æ±Þ¼º Áúȯ
  • subacute inflammation
    ¾Æ±Þ¼º ¿°Áõ
  • subacute myelo-optic neuropathy
    ¾Æ±Þ¼º ô¼ö ½Ã½Å°æº´Áõ
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ
  • centronuclear myopathy
    Áß½ÉÇÙ ±Ùº´Áõ
    Áß¾Ó¿¡ ÇÙÀÌ ÀÖ´Â ±Ù¼¶À¯°¡ ÅÂ¾Æ ±Ù¼¶À¯ÀÇ Æ¯Â¡ÀÎ ±Ù¼¼°ü
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ
  • fingerprint body myopathy
    Áö¹® ¼Òü ±Ùº´Áõ
    ´ë´ÜÈ÷ µå¹® ÁúȯÀ¸·Î À¯¾Æ±âºÎÅÍÀÇ Àü½ÅÀû ±Ù ¼è¾à, À§Ãà, Àú±äÀåµµ¿Í Áö´É ÀúÇϰ¡ ³ªÅ¸³­´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ÀÛÀº À§ÃàµÈ ¼¶À¯¸¦ º¼ ¼ö ÀÖÀ¸¸ç ÀüÀÚÇö¹Ì°æ»ó¿¡¼­ ±Ù ¼¶À¯ÀÇ ¸·°ú ¼öÃà ¹°Áú »çÀÌ¿¡ ƯÀÌÇÑ ºÀÀÔü¸¦ º¸À̴µ¥ ÀÌ ºÀÀÔü´Â ¸·À¸·Î ½ÎÀÌÁö ¾Ê°í º¹ÀâÇÑ ÃþÆÇ ¹è¿­ÀÌ ¸¶Ä¡ Áö¹®°°ÀÌ º¸À̰í ÀÌ·¯ÇÑ ÃþÆÇµéÀº Åé´Ï °°Àº µ¹ÃâÀ» °®°í ÀÖ´Ù.
  • myotubular myopathy
    ±Ù ¼¼°ü¼º ±ÙÁõ
    ¼±Ãµ¼º ºñÁøÇ༺ ±Ù Àå¾Ö·Î ±Ù ¼¶À¯ÀÇ Á߽ɿ¡ ÀåÃàÀ» µû¶ó¼­ ÀÏ·Ä·Î ¹è¿­ÇÏ´Â Á᫐ ÇÙÀÌ ´ë´Ù¼öÀÇ ±Ù ¼¶À¯¿¡ ÀÎÁ¤µÇ´Â °ÍÀÌ Æ¯Â¡À¸·Î Å»ý±âÀÇ ±Ù°ü°ú À¯»çÇÑ Á¡¿¡¼­ ¸í¸íµÇ¾ú´Ù. Á᫐ ÇÙ ÁÖº¯¿¡ ±Ù¿ø¼¶À¯°¡ °á¿©µÈ ºÎºÐÀÌ ÀÖ´Â °æ¿ìµµ ÀÖ´Ù. ±Ù ±äÀå ÀúÇÏ, ¿îµ¿ ¹ß´ÞÀÇ Áö¿¬, ±Ù·Â ÀúÇÏ, ¾È°Ë Çϼö, ¾È¸é±Ù, ¿Ü¾È±Ù, °æ±Ù µîµµ ħ¹üµÈ´Ù. Ç÷û CPK´Â Á¤»óÀ̰ųª °æµµÀÇ »ó½ÂÀ» ³ªÅ¸³½´Ù.
  • nemaline myopathy
    ³×¸»¸°, °£¼Òü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
carcinomatous myopathy <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness.
(27 Sep 1997)
centronuclear myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
rod myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
myopathy <neurology> Any disease of a muscle.
Origin: Gr. Pathos = disease
(18 Nov 1997)
myotubular myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
nemaline myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
ocular myopathy A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
thyrotoxic myopathy Extreme muscular weakness in severe thyrotoxicosis affecting muscles of limbs and trunk as well as those used in speech and swallowing.
(05 Mar 2000)
subacute Somewhat acute, between acute and chronic.
(18 Nov 1997)
subacute bacterial endocarditis Subacute bacterial endocarditis is usually due to Streptococcus viridans or S. Fecalis.
(05 Mar 2000)
subacute care Medical and skilled nursing services provided to patients who are not in an acute phase of an illness but who require a level of care higher than that provided in a long-term care setting. (jcaho, lexikon, 1994)
(12 Dec 1998)
subacute combined degeneration of the spinal cord A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
subacute glomerulonephritis Undesirable term for glomerulonephritis with proteinuria, haematuria and azotemia persisting for many weeks; renal changes are variable, including those of rapidly progressive and membranoproliferative glomerulonephritis.
Synonym: subacute nephritis.
(05 Mar 2000)
subacute granulomatous thyroiditis Thyroiditis with round cell (usually lymphocytes) infiltration, destruction of thyroid cells, epithelial giant cell proliferation, and evidence of regeneration; thought by some to be a reflection of a systemic infection and not an example of true chronic thyroiditis.
Synonym: de Quervain's thyroiditis, giant cell thyroiditis.
(05 Mar 2000)
subacute hepatitis <pathology> This is a form of continuing liver inflammation that results in liver cell death. Causes include viral infection (hepatitis D, hepatitis B, hepatitis C), autoimmune disease, drug ingestion or metabolic causes. Chronic active hepatitis will lead to hepatic failure and death in a small percentage of these patients.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subacute
    (°¢µµ µîÀÌ)¾à°£ ³¯Ä«·Î¿î;(º´ µîÀÌ)¾Æ±Þ¼ºÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á